Background: This systematic review was aimed to evaluate the efficacy and safety of cupping therapy for treating patients with knee osteoarthritis (KOA). Methods: The following databases were searched from their inception until June 2017: the Cochrane Central Register of Controlled Trials, PubMed, EMBASE, and 4 Chinese databases (Wan Fang Data, Chinese Biomedical Literature Database (CBM), VeiPu, and China National Knowledge Infrastructure (CNKI)). Randomized controlled trials (RCTs) assessing the effects of cupping therapy on KOA were included in this systematic review. A quantitative synthesis of the RCTs was conducted using RevMan 5.3 software. Study selection and data extraction and validation were performed independently by 2 reviewers. Cochrane criteria for risk of bias were used to assess the methodological quality of the trials. Results: A total of 5 studies met our inclusion criteria. We analyzed the data from these 5 RCTs involving 535 participants. All included studies were judged to be at high risk for bias. Dry cupping therapy plus Western medicine therapy was more effective than Western therapy alone in reducing the pain scores (mean difference (MD) = -1.79, 95% confidence interval (CI) -2.40 to -1.18; p < 0.01). In addition, the study participants in the dry cupping therapy plus Western medicine therapy group showed significantly greater improvements in the pain (MD = -0.73, 95% CI -1.61 to -0.41; p < 0.01), stiffness (MD = -0.94, 95% CI -1.30 to -0.58; p < 0.01), and physical function (MD = -10.07, 95% CI -13.45 to -6.69; p < 0.01) domains of the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) compared to participants in the Western medicine therapy group. Moreover, when compared with Western medicine therapy alone, a meta-analysis of 4 RCTs suggested statistically significant favorable effects of wet cupping therapy plus Western medicine on the Lequesne Algofunctional Index (LAI) (MD = -3.44, 95% CI -4.21 to -2.68; p < 0.01). Conclusion: There is weak evidence to support the hypothesis that cupping therapy has beneficial effects on reducing the pain intensity and improving the physical function in patients with KOA.

1.
Felson DT, Lawrence RC, Dieppe PA, Hirsch R, Helmick CG, Jordan JM, Kington RS, Lane NE, Nevitt MC, Zhang Y, Sowers M, McAlindon T, Spector TD, Poole AR, Yanovski SZ, Ateshian G, Sharma L, Buckwalter JA, Brandt KD, Fries JF: Osteoarthritis: new insights. Part 1: the disease and its risk factors. Ann Intern Med 2000;133:635-646.
2.
Liu Y, Zhang H, Liang N, Fan W, Li J, Huang Z, Yin Z, Wu Z, Hu J: Prevalence and associated factors of knee osteoarthritis in a rural Chinese adult population: an epidemiological survey. BMC Public Health 2016;16:94.
3.
Jones G: What's new in osteoarthritis pathogenesis? Intern Med J 2016;46:229-236.
4.
Altman R, Brandt K, Hochberg M, Moskowitz R, Bellamy N, Bloch DA, Buckwalter J, Dougados M, Ehrlich G, Lequesne M, Lohmander S, Murphy WA Jr, Rosario-Jansen T, Schwartz B, Trippel S: Design and conduct of clinical trials in patients with osteoarthritis: recommendations from a task force of the Osteoarthritis Research Society. Results from a workshop. Osteoarthritis Cartilage 1996;4:217-243.
5.
Murphy NJ, Eyles JP, Hunter DJ: Hip osteoarthritis: etiopathogenesis and implications for management. Adv Ther 2016;33:1921-1946.
6.
Bruyere O, Cooper C, Pelletier JP, Branco J, Luisa Brandi M, Guillemin F, Hochberg MC, Kanis JA, Kvien TK, Martel-Pelletier J, Rizzoli R, Silverman S, Reginster JY: An algorithm recommendation for the management of knee osteoarthritis in Europe and internationally: a report from a task force of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). Semin Arthritis Rheum 2014;44:253-263.
7.
McAlindon TE, Bannuru RR, Sullivan MC, Arden NK, Berenbaum F, Bierma-Zeinstra SM, Hawker GA, Henrotin Y, Hunter DJ, Kawaguchi H, Kwoh K, Lohmander S, Rannou F, Roos EM, Underwood M: OARSI guidelines for the non-surgical management of knee osteoarthritis. Osteoarthritis Cartilage 2014;22:363-388.
8.
Bijlsma JW, Berenbaum F, Lafeber FP: Osteoarthritis: an update with relevance for clinical practice. Lancet 2011;377:2115-2126.
9.
Towheed TE, Maxwell L, Judd MG, Catton M, Hochberg MC, Wells G: Acetaminophen for osteoarthritis. Cochrane Database Syst Rev 2006;(1):CD004257.
10.
Silverstein FE, Faich G, Goldstein JL, Simon LS, Pincus T, Whelton A, Makuch R, Eisen G, Agrawal NM, Stenson WF, Burr AM, Zhao WW, Kent JD, Lefkowith JB, Verburg KM, Geis GS: Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: a randomized controlled trial. Celecoxib Long-term Arthritis Safety Study. JAMA 2000;284:1247-1255.
11.
Ndaobrumblay SK, Green CR: Predictors of complementary and alternative medicine use in chronic pain patients. Pain Med 2009;11:16-24.
12.
Chirali IZ: 1 - History of cupping therapy; in Chirali IZ (ed): Traditional Chinese Medicine Cupping Therapy, ed 3. London, Churchill Livingstone, 2014, pp 1-16.
13.
Christopoulou-Aletra H, Papavramidou N: Cupping: an alternative surgical procedure used by Hippocratic physicians. J Altern Complement Med 2008;14:899-902.
14.
Mehta P, Dhapte V: Cupping therapy: a prudent remedy for a plethora of medical ailments. J Tradit Complement Med 2015;5:127-134.
15.
Albedah A, Khalil M, Elolemy A, Elsubai I, Khalil A: Hijama (cupping): a review of the evidence. Focus Altern Complement Ther 2011;16:12-16.
16.
Yoo SS, Tausk F: Cupping: East meets West. Int J Dermatol 2004;43:664-665.
17.
Tham LM, Lee HP, Lu C: Cupping: from a biomechanical perspective. J Biomech 2006;39:2183-2193.
18.
Cao H, Han M, Li X, Dong S, Shang Y, Wang Q, Xu S, Liu J: Clinical research evidence of cupping therapy in China: a systematic literature review. BMC Complement Altern Med 2010;10:70.
19.
Kose AA, Karabagli Y, Cetin C: An unusual cause of burns due to cupping: complication of a folk medicine remedy. Burns 2006;32:126-127.
20.
Cao H, Li X, Liu J: An updated review of the efficacy of cupping therapy. PLoS One 2012;7:e31793.
21.
Lee MS, Choi TY, Shin BC, Han CH, Ernst E: Cupping for stroke rehabilitation: a systematic review. J Neurol Sci 2010;294:70-73.
22.
Lee MS, Choi TY, Shin BC, Kim JI, Nam SS: Cupping for hypertension: a systematic review. Clin Exp Hypertens 2010;32:423-425.
23.
Cao H, Zhu C, Liu J: Wet cupping therapy for treatment of herpes zoster: a systematic review of randomized controlled trials. Altern Ther Health Med 2010;16:48-54.
24.
Kim JI, Lee MS, Lee DH, Boddy K, Ernst E: Cupping for treating pain: a systematic review. Evid Based Complement Alternat Med 2011;2011:467014.
25.
Revill SI, Robinson JO, Rosen M, Hogg MI: The reliability of a linear analogue for evaluating pain. Anaesthesia 1976;31:1191-1198.
26.
Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW: Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol 1988;15:1833-1840.
27.
Lequesne MG: The algofunctional indices for hip and knee osteoarthritis. J Rheumatol 1997;24:779-781.
28.
Higgins J, Green S: Cochrane Handbook for Systematic Reviews for Interventions. Version 5.1.0. Chichester, John Wiley & Sons, 2011.
29.
Higgins JP, Thompson SG: Quantifying heterogeneity in a meta-analysis. Stat Med 2002;21:1539-1558.
30.
Sterne JA, Sutton AJ, Ioannidis JP, Terrin N, Jones DR, Lau J, Carpenter J, Rucker G, Harbord RM, Schmid CH, Tetzlaff J, Deeks JJ, Peters J, Macaskill P, Schwarzer G, Duval S, Altman DG, Moher D, Higgins JP: Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ 2011;343:d4002.
31.
Wang B, Liu XR, Hu ZH, Sun AJ, MA YW, Chen YY, Zhang XZ: Yang's wet-cupping therapy for knee osteoarthritis: a multicenter randomized controlled trial. Zhongguo Zhen Jiu 2016;36:113-118.
32.
Teut M, Kaiser S, Ortiz M, Roll S, Binting S, Willich SN, Brinkhaus B: Pulsatile dry cupping in patients with osteoarthritis of the knee - a randomized controlled exploratory trial. BMC Complement Altern Med 2012;12:184.
33.
Wang Q, Yang LQ: Effectiveness of oral glucosamine hydrochloride and cupping therapy in the treatment of knee osteoarthritis. West China Med J 2016;31:816-819.
34.
Zhang L: Treating 58 cases of soft tissue damage type of the knee OA by cupping. Clin J Chin Med 2012;4:44-45.
35.
Ma DH, Li JH: Treating 70 cases of soft tissue damage type of the knee OA by Weizhong acupoint cupping. Ning Xia Med J 2010;32:846-847.
36.
Schulz KF, Chalmers I, Hayes RJ, Altman DG: Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995;273:408-412.
37.
Stack E, Roberts H, Ashburn A: Re: Allocation concealment. BMJ 2012;344:e156.
38.
Tierney JF, Stewart LA: Investigating patient exclusion bias in meta-analysis. Int J Epidemiol 2005;34:79-87.
39.
Sajid MI: Hijama therapy (wet cupping) - its potential use to complement British healthcare in practice, understanding, evidence and regulation. Complement Ther Clin Pract 2016;23:9-13.
40.
Ahmadi A, Schwebel DC, Rezaei M: The efficacy of wet-cupping in the treatment of tension and migraine headache. Am J Chin Med 2008;36:37-44.
41.
Dons'koi BV, Chernyshov VP, Osypchuk DV, Baksheev SM: Repeated cupping manipulation temporary decreases natural killer lymphocyte frequency, activity and cytotoxicity. J Integr Med 2016;14:197-202.
42.
Tagil SM, Celik HT, Ciftci S, Kazanci FH, Arslan M, Erdamar N, Kesik Y, Erdamar H, Dane S: Wet-cupping removes oxidants and decreases oxidative stress. Complement Ther Med 2014;22:1032-1036.
43.
Egger M, Smith GD, Sterne JA: Uses and abuses of meta-analysis. Clin Med (Lond) 2001;1:478-484.
44.
Schulz KF, Altman DG, Moher D: CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. Obstet Gynecol 2010;115:1063-1070.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.